“The invitation to speak about the CNA System at one of the premier oncology meetings worldwide serves as further validation from the medical community of Cota’s approach to data organization"
New York, NY (PRWEB) November 17, 2016
Cota, the leading data and technology platform for precision medicine, presented the Cota Nodal Address™ (CNA) System last week at the 34th Annual Chemotherapy Foundation Symposium in New York during a talk by Dr. Stuart Goldberg, Cota’s Chief Medical Officer entitled “The Digital Oncologist: Using a Prognostically Driven Classification Schema to Identify Variances in Cancer Treatments, Outcomes, and Costs.” The Symposium took place November 9-11th.
The CNA System is a unique, patented method for classifying all patient factors, their diseases, and intended therapies into a digital code that embodies all relevant clinical factors. It ensures that all patients who are medically identical are given the same Cota Nodal Address™, enabling physicians to use data to optimize the care of every individual patient and deliver precision medicine at scale.
“The invitation to speak about the CNA System at one of the premier oncology meetings worldwide serves as further validation from the medical community of Cota’s approach to data organization,” said Dr. Goldberg. “We were delighted to be able to share insights into how the increasing use of the CNA System is helping usher in an era of personalized medicine.”
The CNA System is an integral part of Cota’s broader technology platform, CNA Guided Care™, which turns raw patient data into real-world evidence and enables it to be used for healthcare decision-making with easy-to-use and powerful web-based tools. Beginning first with oncology and expanding across the complete spectrum of medicine, Cota will provide data and technology to help providers, payers, and life sciences companies to optimize decision-making, creating a future where every patient receives the right care at the right place at the right time.
Cota is a technology platform that helps the healthcare system use real-world evidence to make better decisions. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota’s technology enriches raw medical records to create research-grade data, and joins it with a suite of analysis, visualization, and management tools. This enables providers, payers, and life sciences companies to analyze, report on, and research outcomes, costs, treatments, and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and science to help improve the lives of patients everywhere.